Renalytix plc (RNLX) Fundamentals

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
SHARE INFORMATION
Market Cap$ 116,932,381
Shares Outstanding37,445,922
Float20,394,182
Percent Float54.46%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 3,008,552
Latest Fiscal EPS$ -1.62
Latest Fiscal Date2022-06-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions67
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months810,261
Institutional Holdings Percent15.4%
Institutional Sold Previous 3 Months1,658,690
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months-
Insider Holdings Percent22.8
Insider Sold Previous 3 Months-
Insider Shares Owned17,051,740
TRADING INFO
52 Week High$ 14.19
52 Week Low$ 1.05
52 Week High Change$ -76.90
21 Day Moving Average$ 2.383
21 Day Extended Moving Average$ 2.4743
50 Day Moving Average$ 1.9918
50 Day Extended Moving Average$ 2.1395
200 Day Moving Average$ 2.6966
200 Day Extended Moving Average$ 4.1147
10 Day Average Volume39,385
20 Day Average Volume49,922
30 Day Average Volume53,323
50 Day Average Volume56,529
Alpha-0.059358
Beta2.4149
Standard Deviation0.242457
R20.305944
7 Day Price Change$ 0.4127
7 Day Percent Change15.23%
21 Day Price Change$ 0.7177
21 Day Percent Change29.84%
30 Day Price Change$ 1.37
30 Day Percent Change78.44%
Month to Date Price Change$ 1.25
Month to Date Percent Change66.99%
Quarter to Date Price Change$ 1.25
Quarter to Date Percent Change66.99%
180 Day Price Change$ 0.6627
180 Day Percent Change26.94%
200 Day Price Change$ 0.6027
200 Day Percent Change23.92%
Year to Date Price Change$ 1.25
Year to Date Percent Change66.99%

Renalytix plc (RNLX) Key Ratios

PROFITABILITY
EBIT Margin-1,432.9%
EBITDA Margin-1,357.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin27.1%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 2,867,873
Revenue Per Share$ 0.0766
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book5.50
Total Debt To Equity0.60
Int Coverage-27,501.50
Current Ratio2.60
Leverage Ratio1.70
Quick Ratio2.30
Long Term Debt To Capital0.26
VALUATION MEASURES
PE Ratio-1.70
Enterprise Value$ 77,434,741
Price to Sales40.7732
Price to Free Cash-3.60
PE High Last 5 Years0.00
Price To Book5.50
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book5.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover237.70
Invoice Turnover6.90
Assets Turnover0.00
Return Assets-122.43
Return on Equity-168.21
Return on Capital-115.89

Renalytix plc (RNLX) Profile

PROFILE INFO
Issue TypeAD
SEC Type-
Auditor-
CEOJames Renwick McCullough
Emplyoees110
Last Audit-
CIK0001811115
IndustryHealthcare Providers & Services
SectorHealthcare
NAICS-
CONTACT INFO
Address5-7 Cranwood Street
Finsgate
London, EC1V 9EE
Websitehttps://www.renalytix.com
Facsimile-
Telephone+44 2031392910
Email-


Your Recent History
NASDAQ
RNLX
Renalytix
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.